Medication info
Daewoong Alendronate Tablets

Daewoong Alendronate Tablets

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tabletCholecalciferol Concentrate Powder›53.33mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White to pale yellow rectangular tablets
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201403317 · Approved 2014.07.23 · Insurance code 694000700

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults · Children
Adult dose
Take 1 tablet of this medicine once weekly (70 mg/2800 IU or 70 mg/5600 IU) in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3~5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate and its effectiveness. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these administration instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with insufficient dietary calcium and vitamin D intake should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Use in elderly patients (65 years or older): No dosage adjustment is required. Use in patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min) because clinical experience is insufficient.
Child dose
Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis in both postmenopausal women and men.

How to take

Adult dose

Take 1 tablet of this medicine once weekly (70 mg/2800 IU or 70 mg/5600 IU) in the morning with plenty of water, at least 30 minutes before consuming food, beverages, or other medications (see “General Precautions”). The appropriate dose for most patients with osteoporosis is 70 mg/5600 IU once weekly. The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on clinical data from 4 years of treatment. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. Patients at low risk of fracture should be considered for discontinuation after 3~5 years of treatment. The risk of fracture should be reassessed regularly in patients who discontinue treatment. Other beverages or foods, including mineral water and barley tea, and medications may reduce the absorption of alendronate (see “Interactions”). Consuming food within 30 minutes after taking this medicine, or at the same time, may reduce the absorption of alendronate and its effectiveness. Take this medicine as soon as you get up in the morning and swallow it with plenty of water (170∼230 mL) to ensure rapid delivery to the stomach and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after the first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these administration instructions may increase the risk of esophageal adverse reactions (see “Warnings” and “General Precautions”). Patients with insufficient dietary calcium and vitamin D intake should take supplements (see Precautions for Use, 4. General Precautions, 2) Information to Be Provided to Patients (4)). Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, nursing home residents, and patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a one-week supply of 400 IU or 800 IU of vitamin D per day. If a patient taking 1 tablet of this medicine forgets to take it on the scheduled day, take 1 tablet the next morning, resume taking it on the originally scheduled day, and then continue taking it regularly once weekly. However, do not take 2 tablets on the same day. Use in elderly patients (65 years or older): No dosage adjustment is required. Use in patients with renal impairment: No dosage adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 35∼60 mL/min); however, use of this medicine is not recommended in patients with severe renal impairment (creatinine clearance less than 35 mL/min) because clinical experience is insufficient.

Child dose

Children and adolescents (under 18 years of age): Safety and efficacy in children and adolescents have not been established.

Precautions

This medication can irritate the upper gastrointestinal mucosa, leading to esophagitis, esophageal ulcers, and esophageal erosion. If symptoms such as difficulty swallowing, pain during swallowing, pain behind the sternum, or heartburn occur, discontinue use immediately and consult a physician. This medication must be taken with a sufficient amount of water, and you should not lie down for at least 30 minutes after taking it. It should not be administered to patients with esophageal strictures or achalasia that delay esophageal emptying, patients who cannot sit upright for at least 30 minutes, and those with hypersensitivity to any component of this drug. Patients with hypocalcemia or certain genetic diseases such as lactose intolerance should also avoid this medication. While taking this drug, gastrointestinal-related adverse reactions such as abdominal pain, nausea, indigestion, constipation, and diarrhea may occur, and esophagitis or esophageal ulcers may rarely occur. Neurological adverse reactions such as musculoskeletal pain, headache, dizziness, and taste disturbances have also been reported. This medication can interfere with the absorption of calcium supplements or antacids, so it should be spaced at least 30 minutes apart. Caution is needed when co-administering with aspirin or non-steroidal anti-inflammatory drugs, as it may increase the risk of gastrointestinal adverse reactions. During pregnancy, the risks and benefits to the fetus and mother should be carefully considered when taking this medication, and caution is also needed during breastfeeding. It should not be used in children and is not recommended for the elderly or severely impaired renal function patients. When taking this medication, it should be taken in the morning with plenty of water before the first food, drink, or medication, and lying down should be avoided for at least 30 minutes after taking it. This medication should not be chewed or sucked, and especially should not be taken before bedtime or upon waking. Rarely, low-energy fractures of bones may occur with long-term use, so consultation with a doctor is advised if pain occurs. In case of overdose, side effects such as hypocalcemia and gastrointestinal disturbances may occur, requiring immediate medical attention, and induced vomiting is prohibited. This medication should be kept out of the reach of children and care should be taken not to transfer it to another container.

Side effects

esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, hemorrhage, dysphagia, odynophagia, retrosternal pain, heartburn, gastric ulcer, duodenal ulcer, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, musculoskeletal pain, muscle cramps, headache, dizziness, taste disturbance, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, signs of hypocalcemia, peripheral edema, oropharyngeal ulcer, localized jawbone necrosis, joint swelling, low-energy fractures of the femoral neck and other bones, itching, hair loss, Stevens-Johnson syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal, nasopharyngitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Also, it is important to store it at room temperature between 1°C and 30°C, avoiding direct sunlight.

Appearance and packaging

Appearance

White to pale yellow rectangular tablets

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.